PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Feb-2024 Antibe Extends Early Warrant Exercise Incentive Program Businesswire
01-Feb-2024 Deciphera Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference Businesswire
01-Feb-2024 ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke Businesswire
01-Feb-2024 Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance Businesswire
01-Feb-2024 Voom Medical Devices Welcomes Dr. Joël Vernois as Advisor and Editor-in-Chief of Journal of Minimally Invasive Bunion Surgery (JMIBS) Businesswire
01-Feb-2024 Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results Businesswire
01-Feb-2024 Ophthalmic Devices Market Size, Share, Trends and Revenue Forecast till 2030 Ameco Research
01-Feb-2024 Taglich Brothers Initiates Coverage of Cosmos Health Inc. AccessWire
01-Feb-2024 PRODUCTLIFE GROUP ACQUIRES COMMERCIAL EYES, EXPANDING ITS FOOTPRINT IN THE APAC REGION PRODUCTLIFE GROUP
01-Feb-2024 Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2023 Businesswire
01-Feb-2024 Ventegra Announces Its ‘Great Place to Work®’ Certification Businesswire
01-Feb-2024 Retreat Behavioral Health Offers Free Virtual Workshops to Families and Friends of Patients AccessWire
01-Feb-2024 Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering Businesswire
01-Feb-2024 Dermata to Present at the Emerging Growth Conference on February 7, 2024 AccessWire
01-Feb-2024 Thornton & Ross named UK Top Employer for second year running Thornton & Ross
01-Feb-2024 Clinigen’s NaviGATE programme shows a third of rare disease patients are not aware that they can access unlicensed medicines Clinigen 
01-Feb-2024 Maxion Therapeutics Welcomes Dr Arndt Schottelius as New CEO Maxion Therapeutics
01-Feb-2024 NeoPhore raises an additional £9.6m (USD $12.2m) Series B financing extension to further progress drug discovery pipeline NeoPhore Limited
01-Feb-2024 Vivet Therapeutics receives EUR 4.9 million to advance development of a gene therapy for the treatment of cerebrotendinous xanthomatosis Vivet Therapeutics
01-Feb-2024 EnteroBiotix Strengthens its Executive Team, Appoints COO and CFO EnteroBiotix